| 000 | 01704 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518062716.0 | ||
| 264 | 0 | _c20191120 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1178-2013 | ||
| 024 | 7 |
_a10.2147/IJN.S214585 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Cong | |
| 245 | 0 | 0 |
_aDelivery luteolin with folacin-modified nanoparticle for glioma therapy. _h[electronic resource] |
| 260 |
_bInternational journal of nanomedicine _c2019 |
||
| 300 |
_a7515-7531 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 |
_aFolic Acid _xchemistry |
| 650 | 0 | 4 |
_aGlioma _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteolin _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMicelles |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 |
_aPolyesters _xchemistry |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aXu, Qian | |
| 700 | 1 | _aChen, Xinyue | |
| 700 | 1 | _aLiu, Jiagang | |
| 773 | 0 |
_tInternational journal of nanomedicine _gvol. 14 _gp. 7515-7531 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S214585 _zAvailable from publisher's website |
| 999 |
_c30161842 _d30161842 |
||